# Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory) – FDA Inspection, Aug 24, 2022

Source: https://www.keypedia.com/records/fda_inspections/daewoong-pharmaceutical-co-ltd-hyangnam-factory/c1c9c9fa-b993-41ec-b91e-32cad14de631
Source feed: FDA_Inspections

> FDA inspection 1179508 of Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory), August 24, 2022. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1179508
- Company Name: Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)
- Inspection Date: 2022-08-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1288932 - 2024-10-15](https://www.keypedia.com/records/fda_inspections/daewoong-pharmaceutical-co-ltd-hyangnam-factory/3c30ac59-a7d1-4c1a-bc29-92306f4b2dde)
- [FDA Inspection 1031684 - 2017-11-17](https://www.keypedia.com/records/fda_inspections/daewoong-pharmaceutical-co-ltd-hyangnam-factory/4e7d6ab8-8d0d-41dd-a680-ca53f2ac99ec)

Company: https://www.keypedia.com/companies/daewoong-pharmaceutical-co-ltd-hyangnam-factory/2f9e6a6a-9f69-4377-b1ef-5500338ce477

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c